Novo Nordisk has acquired the global rights to United Laboratories’ triple-agonist weight-loss and diabetes drug in a deal ...

The study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).

Alumis and Kaken Pharmaceutical have entered a partnership and licensing agreement for the development of the former’s ...

WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on ...

Trump hinted that the US will impose a 25%+ tariff on pharmaceuticals after giving US companies time to build more ...

The EMA has agreed to review GSK’s application to expand Nucala’s use as an add-on maintenance for individuals with COPD.

Sermonix Pharmaceuticals and Regor have announced a strategic partnership aimed at developing therapeutics in the breast ...

Evolving regulations in sterile manufacturing requires innovation, market knowledge, and investment. How can drug ...

The agency has published a list of 24 high-risk infectious diseases as a reference tool for funders and researchers.

Valneva will work with local health authorities and wholesalers on the French island territory to distribute the vaccines.

The FDA has granted approval for the IND application of Everest Medicines’ tumour-associated antigen (TAA) vaccine, EVM14.

Tempero Bio has raised $70m in Series B financing to advance its lead candidate TMP-301 through two clinical trials for ...